期刊文献+

沙格列汀联合胰岛素泵对2型糖尿病患者FBG、HbA1c、GA、2hPG的影响 被引量:3

Effects of saxagliptin combined with insulin pumps on FBG, HbA1c, GA and 2hPG in type 2 diabetes
下载PDF
导出
摘要 目的:观察并分析沙格列汀联合胰岛素泵对2型糖尿病患者FBG、HbA1c、GA、2hPG的影响。方法:选择2型糖尿病患者92例随机分为对照组(46例)、观察组(46例),对照组给予胰岛素泵治疗,观察组给予沙格列汀联合胰岛素泵治疗,对比分析两组治疗方法对2型糖尿病患者FBG、HbA1c、GA、2hPG的影响。结果:治疗后,观察组GA、2hPG低于对照组(P<0.05);与对照组相比,观察组胰岛素用量更少、血糖达标时间更短(P<0.05)。结论:沙格列汀联合胰岛素泵治疗2型糖尿病可有效调节患者机体GA、2hPG水平,减少胰岛素用量,缩短血糖达标时间,降低低糖血症发生率,安全高效,可帮助患者改善病情,提高疗效。 Objective:To observe and analyze the effects of saxagliptin combined with insulin pumps on FBG, HbA1c, GA and 2hPG in type 2 diabetes.Methods:92 patients with type 2 diabetes were randomly divided into the control group (46 cases) and the observation group (46 cases). The control group were treated with insulin pumps, while the observation group were treated with saxagliptin combined with insulin pumps, with the effects of the two methods on FBG, HbA1c, GA and 2hPG in type 2 diabetes compared and analyzed.Results: After treatment, GA and 2hPG in the observation group were significantly lower than those in the control group ( P <0.05). Compared with the control group, the observation group had fewer insulin dosage and shorter time for blood sugar to reach the target ( P <0.05).Conclusion:Saxagliptin combined with insulin pumps can effectively regulate the levels of GA and 2hPG in patients with type 2 diabetes, reduce the dosage of insulin, shorten the time of blood sugar to reach the target, reduce the incidence of hypoglycemia, which is safe and efficient and can help patients improve their condition and curative effect.
作者 曹丹 CAO Dan(Department of Endocrinology, Jingjiang People's Hospital, Jingjiang 214500, China)
出处 《包头医学院学报》 CAS 2019年第5期66-67,共2页 Journal of Baotou Medical College
关键词 沙格列汀 胰岛素泵 2型糖尿病 Saxagliptin Insulin pump Type 2 diabetes
  • 相关文献

二级参考文献42

  • 1宋燕庆.二甲双胍联合沙格列汀与二甲双胍单药治疗2型糖尿病疗效比较[J].兵团医学,2013(4):18-19. 被引量:2
  • 2中华医学会糖尿病学分会.中国2型糖尿病防治指南/2010年版[M].北京:北京大学医学出版社,2011:5.
  • 3Barnett AH,Charbonnel B,Moses RG,et al.Dipeptidyl peptidase-4 inhibitors in triple oral therapy regimens in patients with type 2 diabetes mellitus[J].Curr Med Res Opin,2015;31(10):1919-31.
  • 4Scirica BM,Braunwald E,Raz I,et al.Heart failure,saxagliptin,and diabetes mellitus:observations from the SAVOR-TIMI 53 randomized tria[J].Circulation,2015;132(6):e120.
  • 5Matthaei S,Catrinoiu D,Celiński A,et al.Randomized,double-blind tria of triple therapy with saxagliptin add-on to dapagliflozin plus metformin in patients with type 2 diabetes[J].Diabetes Care,2015;38(11):2018-24.
  • 6DeF ronzo RA,Hissa MN,Garber AJ,et al.The efficacy and safety of saxagliptin when added to metformin therapy in patients with inad-equately controlled type 2 diabetes with metformin alone[J].Diabetes Care,2009;32(9):1649-55.
  • 7Jadzinsky M,Pfutzner A,Paz-Pacheco E,et al.Saxagliptin given in combination with metformin as initial therapy improves glycae-mic control in patients with type 2 diabetes compared with either monotherapy:A randomized controlled tria[lJ].Diabet Obes Metab,2009;11(6):611-22.
  • 8Yang W,Pan CY,Tou C,et al.Efficacy and safety saxagliptin added to metformin in Asian people with type 2 diabetes melitus:a randomized contrrolled tria[lJ].Diabet Res Clin Pract,2011;94(2):217-24.
  • 9Mosenzon O,Wei C,Davidson J,et al.Incidence of fractures in patients with type 2 diabetes in the SAVOR-TIMI 53 trial[J].Diabetes Care,2015;38(11):2142-50.
  • 10Pech V,Abusaada K,Alemany C.Dipeptidyl peptidase-4 inhibition may stimulate progression of carcinoid tumor[J].Case Rep Endocrinol,2015;2015(1):952019.

共引文献60

同被引文献29

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部